The general objective of this research project is to elucidate the mechanism by which deregulated expression of the c-Myc gene induce B-cell neoplasia. The c-Myc gene encodes a transcription factor which binds DNA specifically as an heterodimer with its partner protein Max and regulates cell proliferation, differentiation and apoptosis by regulating the expression of specific target genes. Despite the substantial progress in elucidating the function of c- Myc, the identity of c-Myc target genes, and therefore the mechanism by which c-Myc contributes to tumorigenesis, remains unknown. We have recently developed novel experimental strategies for the identification of c-Myc target genes based on the use of non-transformed. EBV-immortalized human B cells as substrates for the identification of c-Myc regulated genes. Using this approach, we have identified two novel c-Myc target genes: I) Mxi which codes for a transcription factor which antagonizes the function of c-Myc by heterodimerizing with Max. Mxi expression is induced by c-Myc suggesting that Myc-mediated inducted of Mxi may be part of an autoregulatory circuit that modulates c-Myc function; ii) H-ferritin, whose expression is suppressed by c-Myc, and whose enforced expression can revert part of Myc-dependent transformation phenotype, suggesting that H-ferritin downregulation may represent a critical component of the Myc-dependent biological program. Finally, we have established a novel system allowing for the first time the identification of genes that are regulated upon c- Myc induction in normal quiescent cells (B cells), the physiologic context of c-Myc induction. Based on these approaches, the long term goal of this project is to identify the full spectrum of c-Myc target genes and test their ability, individually or in combination, to reproduce part of the c-Myc-dependent phenotype. The identification of these genes should be instrumental in understanding the mechanism by which c-Myc regulates growth, differentiation and apoptosis, as well as its precise contribution to tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037165-16
Application #
2894604
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Freeman, Colette S
Project Start
1984-03-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pathology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Wu, Kou-Juey; Mattioli, Michela; Morse 3rd, Herbert C et al. (2002) c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene. Oncogene 21:7872-82
Wu, K J; Grandori, C; Amacker, M et al. (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21:220-4
Wu, K J; Polack, A; Dalla-Favera, R (1999) Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 283:676-9
Gu, W; Bhatia, K; Magrath, I T et al. (1994) Binding and suppression of the Myc transcriptional activation domain by p107. Science 264:251-4
Gu, W; Cechova, K; Tassi, V et al. (1993) Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci U S A 90:2935-9
Grignani, F; Lombardi, L; Inghirami, G et al. (1990) Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J 9:3913-22
Inghirami, G; Grignani, F; Sternas, L et al. (1990) Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science 250:682-6
Lombardi, L; Grignani, F; Sternas, L et al. (1990) Mechanism of negative feed-back regulation of c-myc gene expression in B-cells and its inactivation in tumor cells. Curr Top Microbiol Immunol 166:293-301
Bregni, M; Siena, S; Subar, M et al. (1989) Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assay. Haematologica 74:11-4
Seremetis, S; Inghirami, G; Ferrero, D et al. (1989) Transformation and plasmacytoid differentiation of EBV-infected human B lymphoblasts by ras oncogenes. Science 243:660-3

Showing the most recent 10 out of 34 publications